Facilitated Telemedicine in the Bassett Health System
ConditionHCV
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorState University of New York at Buffalo
About this trial
Hepatitis C virus is a leading cause of morbidity and mortality globally with the highest prevalence and incidence among people with opioid use disorder. We aim to establish facilitated telemedicine as a standard of care treatment approach at 3 opioid treatment programs operated by the Catholic Health System. This study is a chart review data analysis to evaluate outcomes of facilitated telemedicine integrated into opioid treatment programs and to evaluate the number of individuals who initiate and complete treatment for hepatitis C virus infection.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
evidence of active HCV infection
Disqualifiers
no evidence of active HCV infection
Trial population
Individuals enrolled in the opioid treatment programs of Catholic Health System
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
200 Participants
are grouped into 1 trial groupGroup A: Individuals with active HCV infection
Trial outcomes
Primary outcomes
1
HCV Treatment Initiation
The time point that HCV treatment is initiated
Time frame
1 year2
HCV Sustained Virologic Response
The time point that HCV cure (sustained virologic response) is achieved
Time frame
1 yearLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: